rituxan

rituxan

美 　英

• 网络美罗华；利妥昔单抗；妥珠单抗

例句

A spokeswoman for Roche said the wholesale cost of two years of Rituxan treatment is about $47, 000.

一位来自罗氏的发言人称，两年的Rituxan治疗总共要花费47000美元。

Rituxan is currently approved as a treatment for non-Hodgkin's lymphoma, chronic lymphocytic leukemia and rheumatoid arthritis.

Rituxan现在已经被批准用于非霍奇金淋巴瘤、慢性淋巴细胞白血病和风湿性关节炎的治疗。

Patients who have been treated with Rituxan and present or develop new neurological signs or symptoms should be evaluated for PML.

已服用利妥昔单抗的患者并存在或发生新的神经体征或症状的患者应评估是否患有PML。

Unlike regular chemotherapy, rituxan does not cause low blood counts or hair loss.

和常规化疗不同的是，美罗华不导致血细胞减少或脱发。

Rituxan is not recommended for use in patients with severe, active infections.

Rituxan不被推荐用于严重、活动性感染的患者。

Two patients have died after being treated with Rituxan for systemic lupus erythematosus (SLE).

两位患者在服用利妥昔单抗治疗系统性红斑狼疮（SLE）后死亡。

Rituxan is being studied for other indications, and is prescribed off-label for other serious diseases and conditions such as SLE.

利妥昔单抗正在研究用于其他适应症，并用于说明书以外的其他严重疾病和情况如系统性红斑狼疮（SLE）。

The sponsor estimates that approximately 10, 000 patients with SLE have been treated with Rituxan.

据估计约有10,000名患有SLE的患者曾用过利妥昔单抗。